Skip to main content
NUMD
OTC Industrial Applications And Services

Tejada Consolidates Control: 9.7% Stake, 100M Super-Votes, and Mandated 1-for-27 Reverse Split

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.024
Mkt Cap
$2.039M
52W Low
$0.008
52W High
$0.136
52W Position info
225% above low
Off High info
82% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

NUMD has more than doubled off its 52-week low of $0.008 on light trading volume (0.1× avg).

Summary

Fred Tejada's Schedule 13D reveals he controls 9.7% of Nu-Med Plus via an irrevocable proxy plus 100M super-voting preferred shares, and the Voting Agreement forces a 1-for-27 reverse split and a 5.5x increase in authorized shares.


Key Events · Ownership and Investor Activity · NUMD

  • Tejada Secures 9.7% Voting Control

    Fred Tejada holds an irrevocable proxy over 8,131,250 shares (9.7% of 83.5M outstanding) held by CEO William Hayde, CFO Keith Merrell, and Hanover International, plus 1,000,000 Series X Super Voting Preferred shares carrying 100,000,000 votes.

  • Mandated 1-for-27 Reverse Split

    The Voting Agreement requires shareholders to vote for a 1-for-27 reverse stock split, an increase in authorized Common Stock from 90M to 500M shares, redomiciling from Utah to Nevada, and a company name change.

  • Series A Conversion Terms Revealed

    Tejada's 129,782 Series A Preferred shares convert at 20:1 into 2,595,640 common shares, but are blocked by a 4.999% beneficial ownership limit (up to 9.999% with 61 days' notice) since he already controls 9.7% via the proxy.

  • Registration Rights Agreement

    The company must file a resale registration statement for Series A conversion shares after shareholder votes, with 18-month piggyback registration rights for Tejada and other Series A holders.


Analysis · NUMD · Industrial Applications And Services

Fred Tejada, the new SVP and Chief Geologist, has secured outsized control of Nu-Med Plus through a combination of 1,000,000 Series X Super Voting Preferred shares (100 votes each, totaling 100,000,000 votes) and an irrevocable proxy over 8,131,250 shares held by CEO William Hayde, CFO Keith Merrell, and Hanover International. The Voting Agreement mandates a 1-for-27 reverse stock split, an increase in authorized shares from 90M to 500M, redomiciling to Nevada, and a name change — all designed to complete the company's pivot to gold mining. With only 83.5M shares outstanding and a market cap near $2M, this control package gives Tejada effective veto power over all shareholder votes while the reverse split and authorized share increase set the stage for massive future dilution.

How filings like this one have moved

In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, NUMD was trading at $0.02 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $2M. The 52-week trading range was $0.01 to $0.14. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

NUMD - Latest Insights

NUMD
Aug 25, 2026, 5:59 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $0.0244
Real-time Price: $0.0244 info
Change: $0 (0%) info
Market Cap: $2.039M info
NUMD
Aug 25, 2026, 8:37 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.0243
Real-time Price: $0.0244 info
Change: +$0.0001 (+0.41%) info
Market Cap: $2.039M info
NUMD
Aug 14, 2026, 3:05 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.0152
Real-time Price: $0.0244 info
Change: +$0.0092 (+61%) info
Market Cap: $2.039M info
NUMD
Jul 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $0.0175
Real-time Price: $0.0244 info
Change: +$0.0069 (+39%) info
Market Cap: $2.039M info
NUMD
Jul 10, 2026, 4:15 PM EDT
Source: TMX Newsfile
Importance Score:
8
Price at Filing: $0.0175
Real-time Price: $0.0244 info
Change: +$0.0069 (+39%) info
Market Cap: $2.039M info